Landry Robert E 的 Form 4 申報
Regeneron Pharmaceuticals, Inc.（REGN），2022/11/2 申報
- 申報編號
- 0001883850-22-000086
- 申報時間
- 2022/11/2
- 交易日
- 2022/10/31-11/1
- 申報延遲
- 2 天
- 10b5-1 計畫
- 表單沒有這欄（2023 年以前）
這份申報列了 12 筆非衍生性交易、1 筆衍生性交易。公開市場賣出合計 $36.5 萬。交易後 2 天申報。
申報人
一份 Form 4 可以有好幾位申報人，例如本人與他控制的基金。各交易表上顯示的是第一位。
| 申報人 | 與公司的關係 |
|---|---|
| Landry Robert ECIK 0001585160 | 高階主管（EVP Finance CFO） |
非衍生性證券（表 I）
普通股等股票的取得與處分，每一列是申報上的一筆。
| 交易日 | 證券 | 交易 | 股數 | 價格 | 金額 | 交易後持股 | 持有方式 | 旗標 |
|---|---|---|---|---|---|---|---|---|
| 2022/10/31 | Common Stock | M行使選擇權取得 | +2,000 | $381.92 | +$763,840 | 30,744 | 直接 | |
| 2022/10/31 | Common Stock | F扣股繳稅處分 | −1,518 | $751.24 | −$1,140,382.32 | 29,226 | 直接 | |
| 2022/11/1 | Common Stock | S賣出處分 | −1 | $750.00 | −$750 | 29,225 | 直接 | |
| 2022/11/1 | Common Stock | S賣出處分 | −40 | $753.23 | −$30,129.2 | 29,185 | 直接 | |
| 2022/11/1 | Common Stock | S賣出處分 | −80 | $754.39F2 | −$60,351.2 | 29,105 | 直接 | |
| 2022/11/1 | Common Stock | S賣出處分 | −81 | $755.46F3 | −$61,192.26 | 29,024 | 直接 | |
| 2022/11/1 | Common Stock | S賣出處分 | −42 | $758.20F4 | −$31,844.4 | 28,982 | 直接 | |
| 2022/11/1 | Common Stock | S賣出處分 | −70 | $759.39F5 | −$53,157.3 | 28,912 | 直接 | |
| 2022/11/1 | Common Stock | S賣出處分 | −13 | $760.90F6 | −$9,891.7 | 28,899 | 直接 | |
| 2022/11/1 | Common Stock | S賣出處分 | −119 | $761.36F7 | −$90,601.84 | 28,780 | 直接 | |
| 2022/11/1 | Common Stock | S賣出處分 | −17 | $762.92 | −$12,969.64 | 28,763 | 直接 | |
| 2022/11/1 | Common Stock | S賣出處分 | −19 | $763.10 | −$14,498.9 | 28,744 | 直接 |
衍生性證券（表 II）
選擇權、認股權證、限制型股票單位等。股數是標的股票的股數；單價與金額是衍生證券本身的價格，交易後持有是衍生證券的單位數。
| 交易日 | 證券 | 交易 | 標的股數 | 單價 | 金額 | 交易後持有 | 持有方式 | 旗標 |
|---|---|---|---|---|---|---|---|---|
| 2022/10/31 | Common Stock | M行使選擇權處分 | −2,000 | $0.00 | $0 | 9,300 | 直接 |
附註與備註
本站收錄交易價格引用的附註、修正申報（Form 4/A）的全部附註，以及申報的備註。其他附註，例如間接持有的方式、交易計畫的細節，請看 SEC EDGAR 上的原文。
- F2
Represents volume-weighted average price of sales of 80 shares of Company stock on November 1, 2022 at prices ranging from $754.20 to $754.86. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 1, 2022 at each separate price.
表 I 有 1 筆交易的價格引用這則附註。
- F3
Represents volume-weighted average price of sales of 81 shares of Company stock on November 1, 2022 at prices ranging from $755.03 to $755.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 1, 2022 at each separate price.
表 I 有 1 筆交易的價格引用這則附註。
- F4
Represents volume-weighted average price of sales of 42 shares of Company stock on November 1, 2022 at prices ranging from $758.15 to $758.67. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 1, 2022 at each separate price.
表 I 有 1 筆交易的價格引用這則附註。
- F5
Represents volume-weighted average price of sales of 70 shares of Company stock on November 1, 2022 at prices ranging from $759.23 to $759.88. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 1, 2022 at each separate price.
表 I 有 1 筆交易的價格引用這則附註。
- F6
Represents volume-weighted average price of sales of 13 shares of Company stock on November 1, 2022 at prices ranging from $760.81 to $760.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 1, 2022 at each separate price.
表 I 有 1 筆交易的價格引用這則附註。
- F7
Represents volume-weighted average price of sales of 119 shares of Company stock on November 1, 2022 at prices ranging from $761.19 to $761.44. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 1, 2022 at each separate price.
表 I 有 1 筆交易的價格引用這則附註。